Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.560
-0.170 (-3.59%)
At close: Feb 27, 2026, 4:00 PM EST
4.610
+0.050 (1.10%)
After-hours: Feb 27, 2026, 7:31 PM EST
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$2,093,840
Market Cap
242.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 213 |
| Arcturus Therapeutics Holdings | 176 |
| Cibus | 159 |
| Coherus Oncology | 158 |
| OmniAb | 114 |
| Orchestra BioMed Holdings | 70 |
| Camp4 Therapeutics | 55 |
| Shattuck Labs | 44 |
ACHV News
- 24 days ago - Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha
- 24 days ago - Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy - Seeking Alpha
- 4 weeks ago - Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - GlobeNewsWire
- 2 months ago - Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week - PRNewsWire
- 4 months ago - Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewsWire
- 4 months ago - Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation - GlobeNewsWire